← SynDRA
NOBILETIN
SynDRA canonical compound SYN0003238 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAP2K1 |
| Mechanism of action | MEK inhibitor |
All known targets
- MAP2K1
- ABCB1
- ABCG2
- RORC
- TAS2R14
- TYR
Mechanisms of action (all sources)
- MEK inhibitor
- ABCG2 INHIBITOR
- TAS2R14 AGONIST
- RORC AGONIST
Drug classes
Cross-references
Synonyms
- Hexamethoxyflavone
- 3',4',5,6,7,8-Hexamethoxyflavone
- 5,6,7,8,3',4'-Hexamethoxyflavone
- UNII-D65ILJ7WLY
- 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one
- 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one
- NSC 76751
- D65ILJ7WLY
- 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-chromen-4-one
- CHEMBL76447
- Nobiletin (Hexamethoxyflavone)
- CHEBI:7602
- NSC76751
- MFCD03273560
- Flavone, 5,6,7,8,3',4'-hexamethoxy
- 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-
- SMR000156231
- CCRIS 9012
- CPD000156231
- Nobiletin, >=97%
- Spectrum2_001697
- Spectrum3_000921
- Spectrum4_001020
- KBioGR_001519
- MLS000574877
- MLS000759462
- MLS000877030
- MLS001424129
- Nobiletin, analytical standard
- SCHEMBL244029
- SPECTRUM1505268
- SPBio_001654
- MEGxp0_000930
- ACon1_000921
- KBio3_001922
- DTXSID30197275
- 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromen-4-one
- HMS2051D09
Look up NOBILETIN in the interactive SynDRA portal →